Marx N - Search Results

1

Loss of CASK Accelerates Heart Failure Development.

Mustroph J, Sag CM, Bähr F, Schmidtmann AL, Gupta SN, Dietz A, Islam MMT, Lücht C, Beuthner BE, Pabel S, Baier MJ, El-Armouche A, Sossalla S, Anderson ME, Möllmann J, Lehrke M, Marx N, Mohler PJ, Bers DM, Unsöld B, He T, Dewenter M, Backs J, Maier LS, Wagner S. Mustroph J, et al. Among authors: marx n. Circ Res. 2021 Apr 16;128(8):1139-1155. doi: 10.1161/CIRCRESAHA.120.318170. Epub 2021 Feb 17. Circ Res. 2021. PMID: 33593074 Free PMC article.

2

C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.

Walcher D, Babiak C, Poletek P, Rosenkranz S, Bach H, Betz S, Durst R, Grüb M, Hombach V, Strong J, Marx N. Walcher D, et al. Among authors: marx n. Circ Res. 2006 Nov 24;99(11):1181-7. doi: 10.1161/01.RES.0000251231.16993.88. Epub 2006 Oct 26. Circ Res. 2006. PMID: 17068290

3

Cardiovascular effects of incretin-based therapies.

Lehrke M, Marx N. Lehrke M, et al. Among authors: marx n. Rev Diabet Stud. 2011 Fall;8(3):382-91. doi: 10.1900/RDS.2011.8.382. Epub 2011 Nov 10. Rev Diabet Stud. 2011. PMID: 22262075 Free PMC article. Review.

4

[Cardiovascular effects of incretin-based therapies].

Lehrke M, Marx N. Lehrke M, et al. Among authors: marx n. Herz. 2012 May;37(3):287-93. doi: 10.1007/s00059-012-3599-8. Herz. 2012. PMID: 22430284 German.

5

New antidiabetic therapies: innovative strategies for an old problem.

Lehrke M, Marx N. Lehrke M, et al. Among authors: marx n. Curr Opin Lipidol. 2012 Dec;23(6):569-75. doi: 10.1097/MOL.0b013e328359b19f. Curr Opin Lipidol. 2012. PMID: 23069986 Review.

6

Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe⁻/⁻ mice.

Burgmaier M, Liberman A, Möllmann J, Kahles F, Reith S, Lebherz C, Marx N, Lehrke M. Burgmaier M, et al. Among authors: marx n. Atherosclerosis. 2013 Dec;231(2):427-35. doi: 10.1016/j.atherosclerosis.2013.08.033. Epub 2013 Sep 5. Atherosclerosis. 2013. PMID: 24267262

7

GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering.

Kahles F, Meyer C, Möllmann J, Diebold S, Findeisen HM, Lebherz C, Trautwein C, Koch A, Tacke F, Marx N, Lehrke M. Kahles F, et al. Among authors: marx n. Diabetes. 2014 Oct;63(10):3221-9. doi: 10.2337/db14-0100. Epub 2014 Jun 19. Diabetes. 2014. PMID: 24947356

8

High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms.

Schuett KA, Lehrke M, Marx N, Burgmaier M. Schuett KA, et al. Among authors: marx n. Front Immunol. 2015 Nov 23;6:591. doi: 10.3389/fimmu.2015.00591. eCollection 2015. Front Immunol. 2015. PMID: 26635805 Free PMC article. Review.

9

Glucose-dependent insulinotropic peptide secretion is induced by inflammatory stimuli in an interleukin-1-dependent manner in mice.

Kahles F, Meyer C, Diebold S, Foldenauer AC, Stöhr R, Möllmann J, Lebherz C, Findeisen HM, Marx N, Lehrke M. Kahles F, et al. Among authors: marx n. Diabetes Obes Metab. 2016 Nov;18(11):1147-1151. doi: 10.1111/dom.12711. Epub 2016 Aug 4. Diabetes Obes Metab. 2016. PMID: 27350651

10

The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism.

Möllmann J, Kahles F, Lebherz C, Kappel B, Baeck C, Tacke F, Werner C, Federici M, Marx N, Lehrke M. Möllmann J, et al. Among authors: marx n. Diabetes Obes Metab. 2017 Apr;19(4):496-508. doi: 10.1111/dom.12839. Epub 2017 Feb 22. Diabetes Obes Metab. 2017. PMID: 27917591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

593 results

Search Page